Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUPH is expected to report earnings to fall 6.68% to 23 cents per share on July 30

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q2'26

Est.

$0.23

Q1'26

Beat

by $0.06

Q4'25

Beat

by $1.38

Q3'25

Beat

by $0.07

Q2'25

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of 25 cents, beating the estimate of 18 cents. With 818.40K shares outstanding, the current market capitalization sits at 2.08B.

View a ticker or compare two or three

Compare

AUPH

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AUPH